K2 Principal Fund, L.P. Horizon Therapeutics Public LTD CO Transaction History

K2 Principal Fund, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $558,772 - $651,804	-5,800 Reduced 28.57%	14,500 $1.49 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $2.18 Million - $2.3 Million	20,300 New	20,300 $2.22 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.